Author

Meng-Yi Li

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Ophiopogonin D Suppresses Non-Small Cell Lung Cancer Progression by Targeting Exosomal MALAT1 to Enhance Dendritic Cell Maturation.

Tumor-immune cell crosstalk critically shapes the progression of non-small cell lung cancer (NSCLC), yet the mechanisms underlying exosome-mediated immune suppression remain incompletely understood. Here, we identify a previously unrecognized exosomal lncRNA-mediated immunoregulatory axis targeted by the natural compou...

Qin-Feng Zhou, Yang Guo, Lei Wang et al. · Pharmacological Research · 0 citations

Review Open access Sep 2026

N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection

N6-methyladenosine (m6A), the most abundant internal RNA modification in eukaryotic cells, has emerged as a critical regulator of antiviral host defense. Increasing evidence indicates that m6A functions beyond conventional post-transcriptional regulation by dynamically coordinating the magnitude, timing, and duration o...

Xian-Feng Hui, Shuo-Xiang Gao, Shi-Huan Ding et al. · Frontiers in Immunology · 0 citations

Aug 2026

TRDMT1-dependent m5C modification of TLR4 mediates the protective effects of Shaoyao decoction in TNBS-induced Crohn's disease.

SYD can alleviate intestinal inflammation, inhibit apoptosis, and protect the intestinal barrier in the CD model, and mechanistic studies indicated that TRDMT1 and TLR4 were involved in the protective effects of SYD against CD-like colitis.

Yonghao Deng, Jing Wang, Meng-Yi Li et al. · International Immunopharmaco... · 0 citations